» Articles » PMID: 35671713

The Decision-Making Process Regarding Ovarian Tissue Cryopreservation in Girls with Turner Syndrome by Patients, Parents, and Healthcare Providers: A Mixed-Methods Study

Overview
Publisher Karger
Date 2022 Jun 7
PMID 35671713
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Ovarian tissue cryopreservation (OTC) has proven to be effective in other patient groups, but the effectiveness in girls with Turner syndrome (TS) is still unclear. Guidelines for counselling about OTC in TS are lacking. The aim of this study was to gain insight into the experiences of patients, parents, and healthcare providers with the decision-making process regarding OTC in girls with TS.

Methods: Within a year after counselling, a survey was sent to 132 girls with TS and their parents. Furthermore, focus groups were conducted with (1) gynaecologists with subspeciality reproductive medicine, (2) paediatric endocrinologists, (3) parents of girls aged 2-12, and (4) parents of girls aged 13-18. Transcripts were analysed using a thematic analysis approach.

Results: The response rate of the survey was 45%. Of the survey respondents, 90% appreciated counselling regarding their future parenting options and considered it an addition to existing healthcare. Girls with TS and their parents indicated that the option of OTC raised hope for future genetic offspring and instantly made them feel that their only option was to seize this opportunity. Gynaecologists and paediatricians found it challenging to truly make families grasp a realistic perspective of OTC in girls with TS.

Discussion And Conclusion: Offering young girls with TS the possibility of fertility preservation in an experimental setting raised high hopes and led to challenges for healthcare providers in ensuring a considered decision. The appropriate moment for counselling should be tailored to the individual and discussed with patient, parents, and paediatrician.

Citing Articles

Clinical practice guidelines for the care of girls and women with Turner syndrome.

Gravholt C, Andersen N, Christin-Maitre S, Davis S, Duijnhouwer A, Gawlik A Eur J Endocrinol. 2024; 190(6):G53-G151.

PMID: 38748847 PMC: 11759048. DOI: 10.1093/ejendo/lvae050.


Navigating fertility dilemmas across the lifespan in girls with Turner syndrome-a scoping review.

van der Coelen S, van der Velden J, Nadesapillai S, Braat D, Peek R, Fleischer K Hum Reprod Update. 2024; 30(4):383-409.

PMID: 38452347 PMC: 11215162. DOI: 10.1093/humupd/dmae005.


Reproductive Outcomes of Women with Turner Syndrome Undergoing Oocyte Vitrification: A Retrospective Multicenter Cohort Study.

Nadesapillai S, Mol F, Broer S, Stevens Brentjens L, Verhoeven M, Heida K J Clin Med. 2023; 12(20).

PMID: 37892640 PMC: 10607490. DOI: 10.3390/jcm12206502.


What are the most common controversial clinical issues in fertility preservation? A content analysis of a collaborative professional online consultation group.

Tsafrir A, BenHaroush A, Hyman J, Karavani G, Imbar T Reprod Biol Endocrinol. 2023; 21(1):77.

PMID: 37620900 PMC: 10463612. DOI: 10.1186/s12958-023-01122-5.


AMH and other markers of ovarian function in patients with Turner syndrome - a single center experience of transition from pediatric to gynecological follow up.

Hagen C, Fischer M, Mola G, Mikkelsen T, Cleemann L, Gravholt C Front Endocrinol (Lausanne). 2023; 14:1173600.

PMID: 37455919 PMC: 10339808. DOI: 10.3389/fendo.2023.1173600.


References
1.
Hamama-Raz Y, Ginossar-David E, Ben-Ezra M . Parental regret regarding children's vaccines-The correlation between anticipated regret, altruism, coping strategies and attitudes toward vaccines. Isr J Health Policy Res. 2016; 5:55. PMC: 5100327. DOI: 10.1186/s13584-016-0116-1. View

2.
Bernard V, Donadille B, Zenaty D, Courtillot C, Salenave S, Brac de la Perriere A . Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome. Hum Reprod. 2016; 31(4):782-8. DOI: 10.1093/humrep/dew012. View

3.
Gravholt C, Andersen N, Conway G, Dekkers O, Geffner M, Klein K . Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017; 177(3):G1-G70. DOI: 10.1530/EJE-17-0430. View

4.
Schleedoorn M, van der Velden J, Braat D, Beerendonk I, van Golde R, Peek R . TurnerFertility trial: PROTOCOL for an observational cohort study to describe the efficacy of ovarian tissue cryopreservation for fertility preservation in females with Turner syndrome. BMJ Open. 2019; 9(12):e030855. PMC: 6924773. DOI: 10.1136/bmjopen-2019-030855. View

5.
Vergier J, Bottin P, Saias J, Reynaud R, Guillemain C, Courbiere B . Fertility preservation in Turner syndrome: Karyotype does not predict ovarian response to stimulation. Clin Endocrinol (Oxf). 2019; 91(5):646-651. DOI: 10.1111/cen.14076. View